on NanoViricides, Inc. (NASDAQ:NNVC)
NanoViricides President to Present at PODD Conference
On October 22, 2024, NanoViricides, Inc. announced that Dr. Anil R. Diwan, the company's President, will present at the PODD Conference. The conference takes place on October 28-29, 2024, at the Westin Boston Seaport District. Dr. Diwan's presentation, scheduled for October 28, focuses on nanomedicines that revolutionize antiviral treatments.
The discussion will highlight the NV-387 drug candidate, which has shown promise against respiratory viruses with excellent safety in Phase 1 clinical trials. NV-387 demonstrated effectiveness in animal models against various viruses including RSV and Influenza A/H3N2. The NanoViricides platform aims to refine drug delivery, offering oral availability and enhanced drug protection against metabolism.
By addressing issues like solubility and bioavailability, the platform seeks to advance drug candidates often excluded from development due to unfavorable PKPD characteristics. NanoViricides envisions further development for treatments like COVID-19 and other viral infections leveraging this technology.
R. H.
Copyright © 2024 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all NanoViricides, Inc. news